Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
at the cutting edge of translational immunology and computational biology, within the Section of Computational Biology in the Department of Medicine and Division of Oncology. Our research focuses on understanding
-
the laboratory of Dr. Malini Raghavan , to study the biology of human leukocyte antigen class I (HLA-I) antigen presentation pathways, with a focus on non-canonical pathways of antigen acquisition and
-
disseminate research findings through publications and presentations. Opportunities to participate in veteran-related research studies are also available. Qualifications Ph.D. in Bioengineering, Biology, or a
-
27636BR Molecular Biosciences Position Overview The University of Kansas Computational Chemical Biology Core facility provides computational resources and expertise to enhance the productivity
-
dynamic group and make a difference in the understanding of prostate and kidney cancer biology using a variety of molecular profiling platforms including next generation sequencing, single cell sequencing
-
degree in biology or related sciences; specialization in cell biology, molecular biology, biochemistry (alternatively: long-term and documented experience in conducting cell cultures); Very good knowledge
-
developing u-85 Atlanta, Georgia, and Montgomery, Alabama corridor. The combined Auburn-Opelika Metropolitan Statistical Area boasts a growing population of over 60,000. The City of Auburn grew 43% in the past
-
ulcerative colitis). We study disease-relevant cell and organ signaling pathways using molecular and cell biology, cutting-edge single-cell technologies, animal models (mice), and human tissues, along with
-
Full Time or Part Time? Full Time Shift Day Work Schedule Summary VP Area U of U Health - Academics Department 00262 - Plastic & Reconstruct Surgery Location Campus City Salt Lake City, UT Type
-
, computational and statistical genetic and bioinformatic methods implementation; vascular biology research using in vitro and in vivo models of cardiovascular diseases, particularly those that disproportionately